234 related articles for article (PubMed ID: 15351906)
1. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.
Stanwell P; Gluch L; Clark D; Tomanek B; Baker L; Giuffrè B; Lean C; Malycha P; Mountford C
Eur Radiol; 2005 May; 15(5):1037-43. PubMed ID: 15351906
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
3. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
4. Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.
Başara I; Örgüç Ş; Coşkun T
Diagn Interv Radiol; 2013; 19(3):221-6. PubMed ID: 23271501
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
7. In vivo proton MR spectroscopy of the breast.
Stanwell P; Mountford C
Radiographics; 2007 Oct; 27 Suppl 1():S253-66. PubMed ID: 18180231
[TBL] [Abstract][Full Text] [Related]
8. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
9. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
[TBL] [Abstract][Full Text] [Related]
10. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
11. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
12. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
13. MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma.
Geraghty PR; van den Bosch MA; Spielman DM; Hunjan S; Birdwell RL; Fong KJ; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
Breast J; 2008; 14(6):574-80. PubMed ID: 19000051
[TBL] [Abstract][Full Text] [Related]
14. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil.
Gribbestad IS; Singstad TE; Nilsen G; Fjøsne HE; Engan T; Haugen OA; Rinck PA
J Magn Reson Imaging; 1998; 8(6):1191-7. PubMed ID: 9848727
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.
Kousi E; Tsougos I; Vasiou K; Theodorou K; Poultsidi A; Fezoulidis I; Kappas C
ScientificWorldJournal; 2012; 2012():754380. PubMed ID: 22645448
[TBL] [Abstract][Full Text] [Related]
16. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
[TBL] [Abstract][Full Text] [Related]
17. Human breast lesions: characterization with proton MR spectroscopy.
Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
[TBL] [Abstract][Full Text] [Related]
18. Characterization of malignant breast tissue of breast cancer patients and the normal breast tissue of healthy lactating women volunteers using diffusion MRI and in vivo 1H MR spectroscopy.
Sah RG; Agarwal K; Sharma U; Parshad R; Seenu V; Jagannathan NR
J Magn Reson Imaging; 2015 Jan; 41(1):169-74. PubMed ID: 24273108
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of spectral selected press sequence in breast lesion characterization.
Lu H; Liu PF; Bao RX; Sun F
Chin Med Sci J; 2006 Dec; 21(4):265-9. PubMed ID: 17249203
[TBL] [Abstract][Full Text] [Related]
20. Proof-of-the-Concept Study on Mathematically Optimized Magnetic Resonance Spectroscopy for Breast Cancer Diagnostics.
Belkić D; Belkić K
Technol Cancer Res Treat; 2015 Jun; 14(3):277-97. PubMed ID: 25246518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
